Treatment results of childhood acute lymphoblastic leukemia in Austria - A report of 20 years' experience

Wiener Klinische Wochenschrift

Volumn 114, Issue 4, 2002, Pages 148-157

  Attarbaschi, Andishe ^a   Mann, Georg ^a   Dworzak, Michael ^a   Urban, Christian ^a   Fink, Franz Martin ^a   Dieckmann, Karin ^a   Riehm, Hansjörg ^a   Gadner, Helmut ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Acute lymphoblastic leukemia (ALL); Prognosis; Relapse; Treatment stratification; Trial

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; HUMAN; INFANT; LEUKOCYTE COUNT; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MINIMAL RESIDUAL DISEASE; PROGNOSIS; RELAPSE; SPLEEN SIZE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRIA; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MULTICENTER STUDIES; NEOPLASM, RESIDUAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK;

EID: 0037186740     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Acute lymphoblastic leukemia
2. Childhood acute lymphocytic leukemia. Study VIII
3. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphoblastic leukemia
4. Five-year follow up of "total therapy" of childhood lymphocytic leukemia
5. Kooperative therapie-studien der kindlichen akuten lymphatischen leukämie (ALL) in österreich - Erfahrungsbericht nach 10 jahren
6. New directions of St. Jude total-therapy protocols: Study X for standard-risk childhood acute lymphoblastic leukemia
7. Non-Hodgkin's lymphoma in children. A progress report on the original patients treated with the LSA2-L2 protocol
8. Die west-berliner studie zur behandlung der akuten lymphoblastischen leukämie des kindes - Erfahrungsbericht nach 6 jahren
9. Fortschritte in der behandlung von leukämien im kindesalter
10. Ergebnisse der studie BFM 76/79 zur behandlung der akuten lymphoblastischen leukämie bei kindern und jugendlichen
11. Die behandlung der akuten lymphoblastischen leukämie im kindes- und jugendalter: Ergebnisse der multizentrischen therapiestudie ALL-BFM 81
12. Die corticosteroid-abhängige dezimierung der leukämiezellzahl im blut als prognosefaktor bei der akuten lymphoblastischen leukämie im kindesalter (Therapiestudie ALL-BFM 83)
13. Childhood acute lymphoblastic leukemia: Results of the Austrian Cooperative study group with the ALL A 84 protocol
14. Abschätzung der tumorzellmasse bei der akuten lymphoblastischen leukämie im kindesalter: Prognostische bedeutung und praktische anwendung
15. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
16. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90
17. Proposals for the classification of the acute leukemias. French-American-British (FAB) cooperative group
18. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: Experience of the BFM trials
19. Frequency and clinical significance of DNA aneuploidy in acute leukemia
20. Non-parametric estimation from incomplete observations
21. Evaluation of survival data and two new rank order statistics arising in its consideration
22. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and aspararginase
23. High-dose cytosine arabinoside therapy for refractory leukemia
24. Survival after relapse in childhood acute lymphoblastic leukemia: Impact of site and time to relapse - The Children's Cancer Group Experience
25. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
26. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia